Pharma & Biotech stands out as one of the few sectors combining high conservation with high emerging change. Strong regulatory constraints, safety obligations, and capital intensity generate extremely high conservation, while scientific innovation cycles and global R&D pipelines inject persistent emergent dynamics. Perception must be high due to societal impact and life-critical value.

Energy and optionality are also elevated, as successful actors can redirect investments, pivot research areas, and leverage global networks. Embeddedness is moderate: tightly coupled to scientific and regulatory ecosystems, but less tied to national economies.

This sector’s signature: structurally rigid, yet strategically explosive.

How to read and use the Spider Chart